RIP-X 55 mg x 60 Capsules – GenX Pharma

GenX Pharma RIP-X 55 mg is a premium three-compound research formulation combining Andarine (S-4), MK-2866 (Ostarine), and GW-501516 (Cardarine) into a single advanced investigational product. Developed exclusively for laboratory research, this formulation enables scientists to investigate the interaction between androgen receptor signaling, PPAR-δ activation, metabolic physiology, and cellular energy regulation through complementary biological mechanisms.

By integrating two Selective Androgen Receptor Modulators (SARMs) with GW-501516, a selective Peroxisome Proliferator-Activated Receptor Delta (PPAR-δ) agonist, RIP-X provides researchers with a comprehensive platform for studying androgen receptor activation, lipid metabolism, mitochondrial biology, protein metabolism, gene transcription, cellular differentiation, and molecular endocrinology.

Each bottle contains 60 capsules, delivering a total of 55 mg of active ingredients per capsule, manufactured by GenX Pharma under stringent pharmaceutical-quality standards. Every batch undergoes rigorous quality testing to ensure exceptional purity, formulation consistency, and dependable laboratory performance.

Key Features

• Premium three-compound research formulation
• 55 mg total active ingredients per capsule
• 60 capsules per bottle
• Contains Andarine (S-4) – 15 mg
• Contains MK-2866 (Ostarine) – 15 mg
• Contains GW-501516 (Cardarine) – 25 mg
• Combines Selective Androgen Receptor Modulators (SARMs) with a PPAR-δ agonist
• High-purity laboratory-grade formulation
• Suitable for investigations involving androgen receptor biology, metabolic physiology, mitochondrial function, lipid metabolism, and molecular endocrinology
• Manufactured under rigorous pharmaceutical-quality standards
• Intended exclusively for laboratory and scientific research applications

How It Works

RIP-X combines three investigational compounds with complementary biological mechanisms, allowing researchers to investigate multiple molecular signaling pathways within a single laboratory model.

• Andarine (S-4) – 15 mg selectively binds to androgen receptors (AR), enabling investigations into tissue-selective signaling, protein metabolism, gene transcription, and musculoskeletal physiology.
• MK-2866 (Ostarine) – 15 mg is a selective SARM extensively researched for its interaction with androgen receptors, providing a model for studying cellular differentiation, receptor pharmacology, and intracellular signaling.
• GW-501516 (Cardarine) – 25 mg is a selective PPAR-δ agonist, enabling investigations into fatty acid oxidation, mitochondrial biology, glucose metabolism, cellular energy production, and metabolic homeostasis.

Together, these complementary mechanisms provide researchers with a comprehensive platform for investigating androgen receptor biology, PPAR-δ signaling, receptor pharmacology, intracellular communication, metabolic regulation, and molecular physiology in controlled laboratory environments.

This formulation is intended exclusively for laboratory and scientific research and is not intended for human consumption.

Contents

Active Ingredients (Per Capsule):

• Andarine (S-4) – 15 mg
• MK-2866 (Ostarine) – 15 mg
• GW-501516 (Cardarine) – 25 mg

Total Active Ingredients: 55 mg per capsule

Packaging: 60 Capsules